NOVAVAX INC

SEC 4/A · Filed

0001104659-26-025366Accepted

Applies to the EDGAR acceptance time.

Other time zone

Amends 0001104659-26-023709.

Insider transactionsEvent date Mar 2, 2026

Grant, award or other acquisition by Draghia-Akli Ruxandra

Security
Non-Statutory Stock Option NQ
Code
A
Shares
139,500
Price per share
0.00
Structured facts
{
  "amendment_scope": "rows_as_filed",
  "code": "A",
  "date": "2026-03-02",
  "direction": "A",
  "exercise_price": "10.11",
  "expiration": "2036-03-02",
  "footnotes": {
    "F1": "This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person\u0027s Form 4 filed on March 5, 2026. All other information remains unchanged from the March 5, 2026 filing.",
    "F2": "One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."
  },
  "owners": [
    {
      "cik": "0002041719",
      "name": "Draghia-Akli Ruxandra",
      "roles": [
        "officer"
      ],
      "title": "EVP, Research \u0026 Development"
    }
  ],
  "ownership": "D",
  "post_shares": "139500",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Non-Statutory Stock Option NQ",
  "shares": "139500",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "139500"
}